Upjohn v. Medtron Labs suit results in seizure of Minoxidil Plus on Aug. 3.
This article was originally published in The Tan Sheet
Executive Summary
UPJOHN v. MEDTRON LABS RESULTS IN MINOXIDIL PLUS PRODUCT SEIZURE Aug. 3 in New York City. The seizure of "Minoxidil Plus" came after Manhattan federal court Judge Shirley Wohl Kram found the Hair & Skin Treatment Center (formerly "New York Hair Labs" and "Medtron") in contempt July 19 of the court's 1990 and 1992 injunctions enjoining the defendant from the "manufacturing, sale, distribution, advertisement, and promotion" of products covered under Upjohn's patents.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning